About Narus Biotechnologies
Narus Biotechnologies is a Healthcare company based in San Francisco (United States) founded in 2015, and was acquired by Cofactor Genomics in February 2016. RNA-based diagnostic tests for neurological disorders are developed. The company was acqui-hired. Its focus areas include Life Sciences, Genomics, Applied Genomics and Clinical Genomics. Its competitors include Veracyte, Cofactor Genomics and Amprion; 3 of its 3 listed competitors have raised funding.
Company details
Narus Biotechnologies was founded in 2015 in San Francisco, United States, within the biotechnology sector. RNA-based diagnostic tests for neurological disorders were developed using a proprietary platform that incorporated custom biomarker panels and bioinformatic analysis. This supported physicians in selecting treatment regimens for conditions including multiple sclerosis, Alzheimers, and Parkinsons disease. The company was acquired by Cofactor Genomics in February 2016 for an undisclosed amount.
- Headquarters San Francisco, United States
- Stage Acquired
- SectorsHealthcare
- Website narusbio.com
- Acquired by Cofactor Genomics (Feb 2016)
- Investors
- Acquired byCofactor Genomics
(Feb 2016)
Investors in Narus Biotechnologies
Narus Biotechnologies has secured backing from 1 investor. Prominent investors backing the company include Cofactor Genomics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Diagnostic assays are developed using RNA sequencing technology. | 2009 | cofactorgenomics.com | San Francisco, United States |
Investor details for Narus Biotechnologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Narus Biotechnologies
2 dated milestones of Narus Biotechnologies across 1 years, from founding to its latest funding, stage changes and deals.
- Founded Narus Biotechnologies is founded.
- Exit Acquired by Cofactor Genomics.
Competitors of Narus Biotechnologies
Narus Biotechnologies has 3 listed competitors in our database, 3 of them funded. They include Veracyte, Cofactor Genomics and Amprion.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| veracyte.com | 2008 | San Francisco, United States | $67.9M | 815 | Genomics-based diagnostic tests for cancer are developed. | |
| cofactorgenomics.com | 2009 | San Francisco, United States | $26.2M | 9 | Diagnostic assays are developed using RNA sequencing technology. | |
| ampriondx.com | 2006 | Houston, United States | $11.76M | 34 | Assay technology for misfolded proteins in neurodegenerative disorders is developed. |
Detailed competitors of Narus Biotechnologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Narus Biotechnologies (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Narus Biotechnologies
Narus Biotechnologies was founded in 2015.
Narus Biotechnologies is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Narus Biotechnologies was founded in 2015 in San Francisco, United States, within the biotechnology sector. RNA-based diagnostic tests for neurological disorders were developed using a proprietary platform that incorporated custom biomarker panels and bioinformatic analysis. This supported physicians in selecting treatment regimens for conditions including multiple sclerosis, Alzheimers, and Parkinsons disease. The company was acquired by Cofactor Genomics in February 2016 for an undisclosed amount.
Narus Biotechnologies's top competitors include Veracyte, Cofactor Genomics and Amprion.
Narus Biotechnologies has 1 investor. Key investors include Cofactor Genomics.
Yes. Narus Biotechnologies was acquired by Cofactor Genomics in February 2016.